Dechra Pharmaceuticals PLC — Director's Dealing 2016

Jun 6, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3271A

Dechra Pharmaceuticals PLC

06 June 2016

6 June 2016

Dechra® Pharmaceuticals PLC

("Dechra" or "the Company")

Director / PDMR shareholding 

Dechra Pharmaceuticals PLC has been notified that on 3 June 2016 Tony Rice, Non-Executive Director, purchased 20,000 ordinary shares in the Company at an average price of £11.407 each.  The highest price paid was £11.4070 and the lowest £11.38

Following this acquisition, Tony rice's beneficial interest in the Company is 20,000 shares (0.02% of the current issued share capital).

For further information, please contact:

Suzana Cross, General Counsel and Company Secretary            

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.  For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHAKADNBBKDNAK